Public-registry site landscape for NCT03391804, a Enteric Hyperoxaluria study sponsored by Allena Pharmaceuticals. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03391804 (registry record) |
| Sponsor | Allena Pharmaceuticals |
| Condition(s) | Enteric Hyperoxaluria; Primary Hyperoxaluria; Hyperoxalemia |
| Phase | PHASE2 |
| Listed sites | 9 |
| Site countries | United States, Germany, United Kingdom |
Eichor generates a preliminary site-risk snapshot for NCT03391804 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →